Le Lézard
Classified in: Health
Subjects: NPT, SVY, AVO, MAT

Let's be clear, THC vapes or other non-regulated, non water-soluble devices are not classified as "e-cigarettes"

The Canadian Vaping Association (CVA) Responds to Canadian Medical Association Journal study on a vaping-related disease diagnosis in an Ontario teen

TORONTO, Nov. 22, 2019 /CNW/ - The CVA is aware of a disturbing lung illness diagnosis that was published in the Canadian Medical Association Journal (CMAJ) on Thursday, November 21. Cases like this are very unsettling, particularly given that it and the other illnesses in the United States are clustered within the last five months. This pattern suggests, and the CMAJ infers, that other substances, such as THC, vitamin E acetate or other non-sanctioned chemicals, have been inappropriately introduced into the product.  As the report suggests, more testing is needed and needed soon.

The Canadian Vaping Association (CNW Group/The Canadian Vaping Association)

It is important to take a step back and redefine nicotine e-liquid vaping. This form of vaping is defined as water-soluble nicotine delivery through an electronic device, a process that has been strictly regulated provincially and federally, with no incident of illness for over a decade. The generalization of the terms "vaping" or "e-cigarettes" to include unregulated, black market, including those containing THC, is highly misleading. In the case of THC vape products, vitamin E acetate has been identified as the cause of the lung illness outbreak seen across North America this past summer.

Based on a preliminary review of the CMAJ findings, the CVA urges caution around the premature conclusions stated in the study. The nature of the bronchiolitis obliterans, or popcorn lung, diagnosis in the study is merely speculative, and based on a single patient diagnosis. In fact, by the authors' own admission, the study has several limitations. The authors admitted they were unable to pinpoint the causative agent(s) responsible for the patient's pulmonary illness, as he vaped a variety of substances of which more than one may be a causative agent for harm.

"The fact that this new study is based on one case, with several limitations, calls into question the conclusiveness of any of the findings. The distinction between this particular case and the wider EVALI diagnosis doesn't isolate e-liquid nicotine vapes as the causal agent of this particular Ontario teen's symptoms." said Darryl Tempest, Executive Director and Lead Advocate of The Canadian Vaping Association. "In fact, the most significant takeaway from the report is that further testing is needed into the root cause of the Ontario teen's illness, as well as other vaping-related illnesses diagnosed across Canada."

The study also highlights the need for tighter regulation of the vaping industry, including marketing, age-restricted sales and rigorous testing of vape products; the CVA has been vocal in its advocacy with the federal and provincial governments and health agencies for these very measures. It is important that vaping-related regulations are updated on a measured and evidence-based approach.

The federal government is also working on toxicology and emissions testing of vaping products. The CVA supports the development of testing standards to ensure Canadians can continue to have access to this life-saving product, and are protected from black market and oil-based vape products that are extremely dangerous to their health. Approximately 40 million people worldwide have found vaping as the most successful harm reduction alternative to combustible tobacco over the past decade. An outright ban on flavours would drive those who rely on vape products as a harm reduction alternative either to the unregulated and unsafe black market for vaping products or back to combustible tobacco.

The correlation between diacetyl and its formation over time in e-liquids containing acetoin - a flavouring replacement used by the flavouring industry to replace diacetyl and acetyl propionyl - is noted in the CMAJ study. To ensure consumer safety, CVA members ensure that expiry dates are clearly labelled on all product packaging of e-liquids, based on their shelf life of two years. 

About the Canadian Vaping Association

The Canadian Vaping Association (thecva.org) is a registered national, not-for-profit organization, established as the voice for the burgeoning Canadian vaping industry. Founded in 2014, the CVA represents over 300 retail and online vaping businesses in Canada.  Our membership does not include tobacco companies or affiliates. The association is the primary liaison with the federal and provincial governments on all legislative and regulatory issues related to the industry. The primary goal of CVA is to ensure that government regulation is reasonable and practical, through the strategy of professional proactive communication and education supplied bilingually to health officers, media, and elected officials.

SOURCE The Canadian Vaping Association

These press releases may also interest you

at 19:16
Today, the U.S. Food and Drug Administration approved Olinvyk (oliceridine), an opioid agonist for the management of moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative...

at 19:15
The "Syringe and Needle Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global syringe and needle market is expected to grow at a CAGR of over 10% during the period 2019-2025 The global...

at 19:00
The "US Acne & Rosacea Market: Insights, Trends & Forecast (2020-2024)" report has been added to ResearchAndMarkets.com's offering. The US acne market is expected to reach US$4.49 billion in 2024, recording growth at a CAGR of 4.12% during the period...

at 18:15
The "Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020" report has been added to ResearchAndMarkets.com's offering. The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to...

at 18:10
Service Corporation International (the "Company") announces that the previously announced cash tender offer for any and all of its 5.375% Senior Notes due 2024 (CUSIP No. 817565 CB8/ ISIN No. US817565CB82) (the "Notes"), which expired today at 5:00...

at 17:50
FSD Pharma Inc. (FRA: 0K9A) ("FSD Pharma" or the "Company") today reported that management's discussion and analysis of financial condition and results of operations ("MD&A") for the three months ended June 30, 2020 have been filed and can be...

News published on 22 november 2019 at 09:00 and distributed by: